28 Jun Ganciclovir and valganciclovir for the preemptive treatment of CMV in adult patients who have undergone allogeneic stem cell transplantation
Introduction Pharmaceutical Services Division requested a systematic review of intravenous ganciclovir and oral valganciclovir for preemptive therapy of cytomegalovirus (CMV) infection in allogeneic stem cell transplant patients. Drug Ganciclovir is indicated for treatment of CMV retinitis in immuno-compromised...